| Identification | Back Directory | [Name]
2,4-Heptadienamide, 6-[(1R,3aS,4E,7aR)-4-[2-[(3R,5R)-3,5-dihydroxycyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-N-hydroxy-4-methyl-, (2E,4E,6R)- | [CAS]
957214-00-5 | [Synonyms]
Triciferol
2,4-Heptadienamide, 6-[(1R,3aS,4E,7aR)-4-[2-[(3R,5R)-3,5-dihydroxycyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-N-hydroxy-4-methyl-, (2E,4E,6R)- | [Molecular Formula]
C26H39NO4 | [MDL Number]
MFCD34179503 | [MOL File]
957214-00-5.mol | [Molecular Weight]
429.59 |
| Chemical Properties | Back Directory | [density ]
1.214±0.06 g/cm3(Predicted) | [storage temp. ]
4°C, protect from light, stored under nitrogen | [form ]
Solid | [pka]
8.98±0.23(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Description]
Triciferol functions as a multiple ligand with combined VDR agonist and HDAC antagonist activities. Triciferol binds directly to the VDR (IC50=87 nM), and functions as an agonist with 1,25D-like potency on several 1,25D target genes. Triciferol induces marked tubulin hyperacetylation, and augments histone acetylation. Antiproliferative and cytotoxic activities[1]. Triciferol (0-10000 nM; 0-72 hours) is significantly more efficacious in suppressing the proliferation of estrogen receptor-negative human MDA-MB231 breast cancer cells[1].Treatment of MCF-7 cells with Triciferol (100-1000 nM) induces ≈2.5-fold higher rates of cell death than equimolar amounts of 1,25D[1]. | [References]
[1]. Tavera-Mendoza LE, et al. Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist. Proc Natl Acad Sci U S A. 2008;105(24):8250-8255. |
|
|